Current perceptions of Canadian autologous blood donors

Vox Sanguinis

Volumn 91, Issue 2, 2006, Pages 157-161

  Banning, M ^a   Bormanis, J ^a   Lander, N ^a   Neurath, D ^a   Rock, G ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Canadian Apheresis Group   (Canada)

Author keywords

Perceptions and motivations of autologous donors

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD TRANSFUSION; CANADA; CONTAMINATION; FEMALE; GYNECOLOGY; HEALTH SURVEY; HEART; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDICS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY; SURGICAL TECHNIQUE; UROLOGY; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; BLOOD TRANSFUSION, AUTOLOGOUS; CANADA; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES;

EID: 33746459777     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2006.00808.x     Document Type: Article

References (13)

1. Cohen JA, Brecher ME: Preoperative autologous blood donation: benefit or detriment? A mathematical analysis. Transfusion 1995; 35:640-644
2. Forgie M, Wells P, Laupacis A, Fergusson D for the International Study of Perioperative Transfusion (ISPOT) Investigators: Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion. Arch Intern Med 1998; 158:610-616
3. Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C, Fink A, Brook R: The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995; 332:719-724
4. Feagan BG, Wong CJ, Johnston WC, Arellano R, Colterjohn N, Karkouti K, Turner K: Transfusion practices for elective orthopedic surgery. CMAJ 2002; 166:310-314
5. Moltzan C, Proulx N, Bormanis J, Lander N, DeGroot H, Rock G: Perceptions and motivations of Canadian autologous blood donors. Transfus Med 2001; 11:177-182
6. Chambers LA, Kruskall MS, Drago SS, Ellis AM: Directed-donor program may adversely affect autologous donor participation. Transfusion 1990; 30:246-248
7. Salonen K: Directed blood donation: a matter of public trust. Health Law Can 1996; 17:10-19
8. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF, Sher G: Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and Human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ 2003; 169:767-773
9. Domen RE, Ribicki LA, Hoeltge GA: An analysis of autologous blood donor motivational factors. Vox Sang 1995; 69:110-113
10. Lee SJ, Liljas B, Churchill WH, Popovsky MA, Stowell CP, Cannon ME, Johannesson M: Perceptions and preferences of autologous blood donors. Transfusion 1998; 38:757-763
11. Peden A, Head M, Ritchie D, Bell J, Ironside J: Preclinical vCJD after blood transfusion in a PRPN codon 129 heterozygous patient. Lancet 2004; 264:527-529
12. Rock G, Jones TG, Berger R, Bormanis J, Guilivi A, ElSaadany S, Afzal M, Beard J, Neurath D: A review of nearly two decades in an autologous blood program, the rise and fall of activity. Transfus Med 2006; in press
13. Lawrence V, Silverstein J, Cornell J, Pederson T, Noveck H, Carson J: Higher Hb level is associated with better early functional recovery after hip fracture repair. Transfusion 2003; 43:1717-1722